Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov 1;2(11):e26328.
doi: 10.4161/onci.26328. Epub 2013 Oct 9.

Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells

Affiliations

Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells

Frédérique Végran et al. Oncoimmunology. .

Abstract

Survivin-3B (S-3B), an alternative splice isoform of survivin, plays a key role in tumorigenesis. S-3B promotes the escape of malignant cells from immune recognition by blocking the cytotoxicity of natural killer (NK) cells. Such an effect reflects the ability of S-3B to interfere with the assembly of the so-called "death-inducing signaling complex" upon the interaction of FAS with its ligand (FASL). S-3B also inhibits the activation of caspase-6, thus increasing the resistance of neoplastic cells to granzyme B and various chemotherapeutics.

Keywords: caspase-6; caspase-8; survivin-3B; treatment response; tumor escape; tumorigenesis.

PubMed Disclaimer

Figures

None
Figure 1. Involvement of survivin-3B in cancer initiation, progression, and dissemination. The defects in alternative splicing that normally accompany oncogenesis can result in the production of survivin-3B (S-3B). Pre-malignant cells are normally detected by the immune system, in particular by natural killer (NK) cells. Upon such a recognition, activated NK cells attempt to eliminate target cells by triggering FAS-dependent cell death and by secreting granzyme B. However, S-3B inhibits both the extrinsic and the intrinsic pathways of apoptosis. In this way, pre-malignant cells can escape elimination by the immune system and generate neoplastic lesions. In addition, S-3B inhibits the apoptotic response of cancer cells to chemotherapy and perhaps favors their metastatic dissemination. Dashed lines summarize several events occurring upstream of the represented process.

Similar articles

Cited by

References

    1. Végran F, Mary R, Gibeaud A, Mirjolet C, Collin B, Oudot A, Charon-Barra C, Arnould L, Lizard-Nacol S, Boidot R. Survivin-3B potentiates immune escape in cancer but also inhibits the toxicity of cancer chemotherapy. doi: 10.1158/0008-5472.CAN-13-0036. Forthcoming. - DOI - PubMed
    1. Badran A, Yoshida A, Ishikawa K, Goi T, Yamaguchi A, Ueda T, Inuzuka M. Identification of a novel splice variant of the human anti-apoptopsis gene survivin. Biochem Biophys Res Commun. 2004;314:902–7. doi: 10.1016/j.bbrc.2003.12.178. - DOI - PubMed
    1. Knauer SK, Bier C, Schlag P, Fritzmann J, Dietmaier W, Rödel F, Klein-Hitpass L, Kovács AF, Döring C, Hansmann ML, et al. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle. 2007;6:1502–9. doi: 10.4161/cc.6.12.4305. - DOI - PubMed
    1. Sawai K, Goi T, Hirono Y, Katayama K, Yamaguchi A. Survivin-3B gene decreases the invasion-inhibitory effect of colon cancer cells with 5-fluorouracil. Oncol Res. 2010;18:541–7. doi: 10.3727/096504010X12767359113848. - DOI - PubMed
    1. Fregni G, Perier A, Avril MF, Caignard A. NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies. Oncoimmunology. 2012;1:38–47. doi: 10.4161/onci.1.1.18312. - DOI - PMC - PubMed

LinkOut - more resources